In a report released yesterday, Cory Jubinville, PhD from LifeSci Capital maintained a Buy rating on Crinetics Pharmaceuticals (CRNX – ...
Avadel's stock surged 28% in premarket trading after court ruling in FDA's favor against Jazz Pharmaceuticals in a suit over ...
Proceeds expected to support the upcoming planned launches and fund the continued development of Niktimvo and revumenibExpected to fund Syndax ...
The data surveyed by Reuters came from pharmaceutical regulators in Australia ... manufacture semaglutide-based medicines and that their products are shipped overseas. At least three of these ...
Shares in Avadel Pharmaceuticals rose more than 16% after a court ruled in favor of the Food and Drug Administration in a lawsuit brought by Jazz Pharmaceuticals regarding the approval of Lumryz, its ...
A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell/File Photo The number of sexually transmitted ...
The company will invest part of the divestment proceeds in its growing pipeline of value adding and specialty pharmaceutical products. In addition, the company is exploring different strategic options ...
The Federal Ministry of Health and Social Welfare is set to implement zero Value Added Tax and excise duties on pharmaceutical products and medical devices. A statement signed on Thursday by the ...
Now, some of them are looking for alternatives as geopolitical tensions rise. From big pharmaceutical companies such as AstraZeneca to small biotechnology firms like Amicus Therapeutics of New ...
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
that enable the manufacturing of pharmaceutical products with minimal human intervention. 3 Pharma 4.0 has enabled a significant reduction in resource utilization. A higher data density inspired ...
The pharmaceutical value chain model depicted in Figure 1 covers a full range of activities that are required to bring a product from conception to final consumer. The key players in the chain are ...